STEVENSON, Md., June 26, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Zoompass Holdings, Inc. (OTC:ZPAS) (“Zoompass” or the “Company”) securities during the period between April 24, 2017 and May 24, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until July 31, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Zoompass securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Zoompass unlawfully engaged in a scheme to promote the Company’s stock and discovery of the conduct would subject the Company to heightened regulatory scrutiny and potential criminal sanctions.
According to the complaint, following a May 9, 2017 announcement that the Company was requested by the OTC Markets Group, Inc. to comment on recent trading and promotional activity, and a May 25, 2017 article alleging that Zoompass has erroneously denied its involvement with a scheme to promote the stock and hidden a pump-and-dump scheme, the value of Zoompass shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Zoompass securities purchased on or after April 24, 2017 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 



